Evidence map›Paper›PMID 42773192›Full record

ReviewPathologie (Heidelberg, Germany)2026

[The dysplastic nevus].

Wolfgang Weyers

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Pathologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Wolfgang WeyersZentrum für Dermatopathologie Freiburg, Engelbergerstraße 19, 79106, Freiburg, Deutschland. ww@zdpf.de.ORCID http://orcid.org/0009-0002-4590-3732

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysplastic nevus is a controversial category of melanocytic nevi. Formerly regarded as "formal histogenetic precursors of melanoma" or intermediate lesions in the progression of "common acquired nevi" to melanoma, dysplastic nevi are now considered to be benign melanocytic nevi that may simulate melanoma histopathologically. The dysplastic nevus is a very common type of melanocytic nevus. It is limited to the epidermis and papillary dermis, with the epidermal component extending beyond the dermal one; composed mostly of melanocytes with small, monomorphous nuclei; and also known as Clark's nevus. Based on an abundance of histopathologic criteria, distinction from melanoma is usually possible even in the case of some unsual findings. The term "dysplasia," originally introduced to signify diagnostic uncertainty, remains problematic because it suggests a distinct biologic quality. When employing the term "dysplastic nevus," it should be made clear whether one is referring to the common type of nevus named after Clark or whether one is trying to signify diagnostic uncertainty.

Indexed as

EpidermisHistopathologyMelanocytesMelanomaPigmented nevus

Identifiers

PMID42773192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.